Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > Other Vaccine candidates

<< Previous

Bullboard Posts

Next >>

Post by Red~Oneon Feb 08, 2021 10:13am

57 Views

Post# 32499715

Other Vaccine candidates

Good to see other Vaccine candidates doing well today, Hope VXL can move to the $10's soon. Shareholders are forgiving VAXART today it's up $1.18 so far (much to the dismay of our own local basher here) Good to see what VXL can do one day soon

<< Previous

Bullboard Posts

Next >>

The top TSX healthcare stocks under $1